30 marzo 2015
Patients with chronic myelomonocytic leukemia have limited treatment options, and those that exist are effective only in fewer than half of patients. Now, a new study identifies a panel of genetic markers that predicted which tumor samples would likely respond to treatment.
http://feeds.sciencedaily.com/~r/sciencedaily/~3/Im16i4AS4f0/150330173837.htm
